Medicamen Biotech logo

Medicamen Biotech MD, chairman, board of directors and AGM

NSE: MEDICAMEQBSE: 531146Pharmaceuticals & BiotechnologySmall Cap

Last close ₹253.35down ₹11.80 (4.45%)BSE ₹253.75

Share price at the NSE close on 23 Oct 2026. Previous close ₹265.15.

52-week range of traded prices to 23 Oct 2026
₹212.40Low, 29 Jun 2026₹447.65High, 25 Nov 2025
Market cap
₹344 Cr1,991st largest listed
P/E
Earlier quarters restated in the year
P/B
1.2
Dividend yield
0.39%
ROCE
3.7%
Debt to equity
0.17
Volume, NSE
20,122

Medicamen Biotech board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonRahul Bishnoi
  • Company Secretary and Compliance OfficerParul Choudhary

10 directors5 independent1 executive4 non-executive

  • Ashwani Kumar SharmaExecutive · joined Aug 2025 · reappointed Sep 2025 · 60 months as independent · 2 listed boards · 2 committee seats
  • Rahul Bishnoi · ChairpersonNon-executive · joined Dec 2015 · 2 listed boards
  • Sanjay BansalNon-executive · joined Feb 2016 · 1 listed board
  • Suresh Kumar SinghNon-executive · joined Dec 2015 · 2 listed boards
  • Sumita DwivediIndependent · joined Nov 2018 · 60 months as independent · 2 listed boards · 2 as independent · 2 committee seats
  • Sangeeta BishnoiIndependent · joined Feb 2019 · 60 months as independent · 2 listed boards · 2 as independent
  • Vimal Kumar ShrawatNon-executive · joined Feb 2019 · 2 listed boards
  • Ravi Kumar BansalIndependent · joined May 2019 · 60 months as independent · 2 listed boards · 2 as independent
  • Shaival SaurabhIndependent · joined Aug 2025 · 60 months as independent · 2 listed boards · 2 as independent · 2 committee seats
  • Sham GoelIndependent · joined Aug 2025 · 60 months as independent · 2 listed boards · 2 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

2 directors who left
  • Arun Kumar, left 26 Feb 2026: Tenure Completion
  • Harish Pande, left 26 Feb 2026: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 11 Jun 20266 of 10 present2 independent · 14 days in between
    • 27 May 20269 of 10 present4 independent · 38 days in between
    • 18 Apr 20267 of 10 present3 independent · 63 days in between
    • 13 Feb 20266 of 12 present3 independent

  • Audit Committee

    Chair Sham Goel

    Ashwani Kumar Sharma, Sumita Dwivedi

    • 27 May 20263 of 3 present2 independent · 102 days in between
    • 13 Feb 20264 of 5 present3 independent

  • Nomination and remuneration committee

    Chair Sham Goel

    Sangeeta Bishnoi, Sumita Dwivedi

    • 18 Apr 20263 of 3 present3 independent · 63 days in between
    • 13 Feb 20264 of 5 present3 independent

  • Stakeholders Relationship Committee

    Chair Sham Goel

    Ashwani Kumar Sharma, Sumita Dwivedi

    • 27 May 20263 of 3 present3 independent · 57 days in between
    • 30 Mar 20262 of 3 present2 independent · 13 days in between
    • 16 Mar 20262 of 3 present2 independent · 30 days in between
    • 13 Feb 20264 of 5 present3 independent

  • Risk Management Committee

    Chair Sham Goel

    Ashwani Kumar Sharma, Sumita Dwivedi

    • 27 May 20263 of 3 present3 independent · 102 days in between
    • 13 Feb 20262 of 3 present2 independent

  • Corporate Social Responsibility Committee

    Chair Sham Goel

    Sanjay Bansal, Suresh Kumar Singh

    • 27 May 20263 of 3 present1 independent · 102 days in between
    • 13 Feb 20263 of 4 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • M/s Rai Qimat & AssociatesPeer-review certificate valid to Nov 2026

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Medicamen Biotech AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Medicamen Biotech dividend history

Annual general meeting, 26 Sep 2026

12,110 shareholders on the register on 19 Sep 2026; present: 1 promoter and 183 others; votes counted by MANOJ KUMAR JAIN / AMJ & ASSOCIATES.The company's voting result (opens in a new tab)

  1. TO RECEIVE, CONSIDER AND ADOPT THE AUDITED STANDALONE FINANCIAL STATEMENTS OF TH COMPANY FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026 AND THE REPORTS OF THE BOARD OF DIRECTORS AND STATUTORY AUDITOR THEREONMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 46.07% · promoters 100.00% · institutions 0.00% · other public 9.44%

  2. TO RECEIVE, CONSIDER AND ADOPT THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026 AND THE REPORT OF THE STATUTORY AUDITOR THEREON
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 46.07% · promoters 100.00% · institutions 0.00% · other public 9.44%

  3. TO DECLARE DIVIDEND ON EQUITY SHARES
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 46.07% · promoters 100.00% · institutions 0.00% · other public 9.44%

  4. TO RE-APPOINT MR SURESH KUMAR SINGH (DIN:00318015) AS A DIRECTOR LIABLE TO RETIRE BY ROTATION
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 46.07% · promoters 100.00% · institutions 0.00% · other public 9.44%

  5. TO RE-APPOINT MR SANJAY BANSAL (DIN: 00121667) AS A DIRECTOR LIABLE TO RETIRE BY ROTATION
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 46.07% · promoters 100.00% · institutions 0.00% · other public 9.44%

  6. RATIFICATION OF REMUNERATION OF COST AUDITORS FOR THE FINANCIAL YEAR ENDING ON 31.03.2027
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 46.07% · promoters 100.00% · institutions 0.00% · other public 9.44%

  7. TO APPROVE MATERIAL RELATED PARTY TRANSACTIONS WITH SHIVALIK RASAYAN LIMITED (HOLDING COMPANY)
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 46.07% · promoters 100.00% · institutions 0.00% · other public 9.44%

  8. TO APPROVE MATERIAL RELATED PARTY TRANSACTIONS WITH MEDICAMEN LIFE SCIENCES PRIVATE LIMITED (SUBSIDIARY COMPANY)
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 46.07% · promoters 100.00% · institutions 0.00% · other public 9.44%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 26 Sep 2025, 9 resolutions

11,522 shareholders on the register on 19 Sep 2025; present: 1 promoter and 129 others; votes counted by Mnaoj Kumar Jain / AMJ & Associates.The company's voting result (opens in a new tab)

  1. To consider and adopt the Audited Financial Statements (Standalone & Consolidated) of the Company for the financial year ended on March 31, 2025 and the reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

  2. To confirm and to declare a final dividend on the equity shares for the financial year 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

  3. To appoint a Director in place of Mr. Rahul Bishnoi (DIN: 00317960), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

  4. To appoint a Director in place of Dr Vimal Kumar Shrawat (DIN: 08274190), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

  5. Ratification of Remuneration of Cost Auditors.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

  6. Approval for appointment of Mr. Ashwani Kumar Sharma (DIN: 00325634) as Whole-time Director to be designated as Executive Director of the Company for a period of five years.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

  7. To Appoint Mr. Sham Goel (DIN: 02183287) as Non-Executive Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

  8. To Appoint Mr. Shaival Saurabh (DIN: 01971944) as Non-Executive Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

  9. To appoint M/s AMJ & Associates, Company Secretaries as Secretarial Auditor of the Company.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.20% · promoters 100.00% · institutions 3.36% · other public 11.42%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 26 Mar 2025, 2 resolutions

10,947 shareholders on the register on 19 Feb 2025; present: 1 promoter and 126 others; votes counted by Manoj Kumar Jain / AMJ & Associates.The company's voting result (opens in a new tab)

  1. ISSUANCE OF 13,00,000 EQUITY SHARES TO THE PERSONS BELONGING TO “NON-PROMOTER” CATEGORY ON PREFERENTIAL BASIS.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.77% · promoters 100.00% · institutions 0.00% · other public 8.50%

  2. ISSUANCE OF 6,55,000 FULLY CONVERTIBLE WARRANTS (“WARRANTS”) TO THE PERSONS BELONGING TO “PROMOTER” AND “NON-PROMOTER” CATEGORY ON PREFERENTIAL BASIS
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 47.77% · promoters 100.00% · institutions 0.00% · other public 8.50%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 26 Sep 2024, 5 resolutions

Present: 1 promoter and 131 others.The company's voting result (opens in a new tab)

  1. To consider and adopt the Audited Financial Statements (Standalone & Consolidated) of the Company for the financial year ended on March 31, 2024 and the reports of the Board of Directors and Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 54.84% · other public 0.00%

    Turnout: all 45.80% · promoters 96.34% · institutions 0.10% · other public 7.85%

  2. To confirm and to declare a final dividend on the equity shares for the financial year 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 45.80% · promoters 96.34% · institutions 0.10% · other public 7.85%

  3. To appoint a Director in place of Mr. Suresh Kumar Singh (DIN: 00318015), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 45.80% · promoters 96.34% · institutions 0.10% · other public 7.85%

  4. To appoint a Director in place of Mr. Sanjay Bansal (DIN: 00121667), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 45.80% · promoters 96.34% · institutions 0.10% · other public 7.85%

  5. Ratification of Remuneration of Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 45.80% · promoters 96.34% · institutions 0.10% · other public 7.85%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 27 Sep 2023, 9 resolutions

Present: 2 promoters and 132 others.The company's voting result (opens in a new tab)

  1. 1 - To receive, consider and adopt the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 2023 together with the reports of the board of directors and the auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

  2. To confirm and to declare a final dividend on the equity shares for the financial year 2022-23.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

  3. To appoint a Director in place of Mr. Rahul Bishnoi (DIN: 00317960), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

  4. To appoint a Director in place of Mr. Ashwani Kumar Sharma (DIN: 00325634), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

  5. Re-appointment of Ms. Sumita Dwivedi (DIN: 08218640) as Non-Executive Independent Director of the Company
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

  6. Re-appointment of Ms. Sangeeta Bishnoi (DIN: 08288998) as Non-Executive Independent Director of the Company.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

  7. Re-appointment of Mr. Arun Kumar (DIN: 07031730) as Non-Executive Independent Director of the Company.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

  8. Re-appointment of Dr. Ravi Kumar Bansal (DIN: 08462513) as Non-Executive Independent Director of the Company.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

  9. Ratification of Remuneration of Cost Auditors for the FY 2023-24
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.56% · promoters 100.00% · institutions 0.10% · other public 34.33%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 27 Sep 2022, 7 resolutions

Present: 2 promoters and 110 others.The company's voting result (opens in a new tab)

  1. TO RECEIVE, CONSIDER AND ADOPT THE AUDITEDSTANDALONE FINANCIAL STATEMENTS OF THEnnCOMPANY FOR THE FINANCIAL YEAR ENDEDMARCH 31, 2022, TOGETHER WITH THE REPORTSOF THE BOARD OF DIRECTORS AND THE AUDITORSTHEREON.nMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.18% · promoters 100.00% · institutions 0.08% · other public 33.24%

  2. TO RECEIVE, CONSIDER AND ADOPT THE AUDITEDCONSOLIDATED FINANCIAL STATEMENTS OF THEnnCOMPANY FOR THE FINANCIAL YEAR ENDED MARCH31, 2022, TOGETHER WITH THE REPORT OF THEnnAUDITORS THEREON.n
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.18% · promoters 100.00% · institutions 0.08% · other public 33.24%

  3. TO DECLARE DIVIDEND ON THE EQUITY SHARES FORTHE FINANCIAL YEAR ENDED MARCH 31, 2022.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.18% · promoters 100.00% · institutions 0.08% · other public 33.24%

  4. TO APPOINT A DIRECTOR IN PLACE OF MR. SANJAYBANSAL (DIN: 00121667), WHO RETIRES BYnnROTATION AND BEING ELIGIBLE, OFFERS HIMSELFFOR RE-APPOINTMENT.n
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.18% · promoters 100.00% · institutions 0.08% · other public 33.24%

  5. TO APPOINT A DIRECTOR IN PLACE OF DR. VIMALKUMAR SHRAWAT (DIN: 08274190), WHO RETIRESnnBY ROTATION AND BEING ELIGIBLE, OFFERSHIMSELF FOR RE-APPOINTMENT.n
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.18% · promoters 100.00% · institutions 0.08% · other public 33.24%

  6. RE-APPOINTMENT OF STATUTORY AUDITORS OFTHE COMPANY TO CONSIDER AND IF THOUGHTnnFIT, TO PASS THE FOLLOWING RESOLUTION AS AN ORDINARY RESOLUTIONn
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.18% · promoters 100.00% · institutions 0.08% · other public 33.24%

  7. Ratification of Remuneration of Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 62.18% · promoters 100.00% · institutions 0.08% · other public 33.24%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 26 Aug 2022, 2 resolutions

Present: 2 promoters and 89 others.The company's voting result (opens in a new tab)

  1. Issuance of up-to 4, 34,500 Equity Shares on preferential basis.
    SpecialPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 63.28% · promoters 100.00% · institutions 100.00% · other public 34.45%

  2. Issuance of up-to 63,500 Fully Convertible Warrants on preferential basis.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.90% · promoters 100.00% · institutions 0.12% · other public 34.45%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 26 Sep 2024, 2 fund houses

  • To consider and adopt the Audited Financial Statements (Standalone & Consolidated) of the Company for the financial year ended on March 31, 2024 and the reports of the Board of Directors and Auditors thereonMoreLess
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundNon-compliant with SEBI (SBEB & SE) Regulations, 2021: Lack of clarity in the Scheme w.r.t Exercise Price or Pricing Formula.
    1 for1 against
  • To confirm and to declare a final dividend on the equity shares for the financial year 2023-24.
    2 for0 against
  • To appoint a Director in place of Mr. Suresh Kumar Singh (DIN: 00318015), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation
    2 for0 against
  • To appoint a Director in place of Mr. Sanjay Bansal (DIN: 00121667), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation
    2 for0 against
  • Ratification of Remuneration of Cost Auditors
    2 for0 against

Mutual fund votes, meeting of 27 Sep 2023, 1 fund house

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • 1 - To receive, consider and adopt the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 2023 together with the reports of the board of directors and the auditors thereonMoreLess
    1 for0 against
  • To confirm and to declare a final dividend on the equity shares for the financial year 2022-23.
    1 for0 against
  • To appoint a Director in place of Mr. Rahul Bishnoi (DIN: 00317960), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation
    1 for0 against
  • To appoint a Director in place of Mr. Ashwani Kumar Sharma (DIN: 00325634), who retires by rotation and being eligible, offers himself for re-appointment as a Director liable to retire by rotation.
    1 for0 against
  • Re-appointment of Ms. Sumita Dwivedi (DIN: 08218640) as Non-Executive Independent Director of the Company
    1 for0 against
  • Re-appointment of Ms. Sangeeta Bishnoi (DIN: 08288998) as Non-Executive Independent Director of the Company.
    1 for0 against
  • Re-appointment of Mr. Arun Kumar (DIN: 07031730) as Non-Executive Independent Director of the Company.
    1 for0 against
  • Re-appointment of Dr. Ravi Kumar Bansal (DIN: 08462513) as Non-Executive Independent Director of the Company.
    1 for0 against
1 proposal not matched to one resolution
  • Ratification of remuneration of Rs.1,50,000 plus applicable taxes and out-of-pocket expenses incurred in connection with the cost audit payable to SPB and Co., Cost Accountants (Firm Registration No. 102586), who are appointed by the Board of Directors of the Company on the recommendation of the Audit Committee, as Cost Auditors of the Company to conduct audit of the cost records maintained by the Company as prescribed under the Companies (Cost Records and Audit) Rules, 2014, as amended from time to time, for the financial year ending March 31, 2024.MoreLess
    1 for0 against
2 earlier meetings

Mutual fund votes, meeting of 27 Sep 2022, 1 fund house

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • TO RECEIVE, CONSIDER AND ADOPT THE AUDITEDSTANDALONE FINANCIAL STATEMENTS OF THEnnCOMPANY FOR THE FINANCIAL YEAR ENDEDMARCH 31, 2022, TOGETHER WITH THE REPORTSOF THE BOARD OF DIRECTORS AND THE AUDITORSTHEREON.nMoreLess
    1 for0 against
  • TO RECEIVE, CONSIDER AND ADOPT THE AUDITEDCONSOLIDATED FINANCIAL STATEMENTS OF THEnnCOMPANY FOR THE FINANCIAL YEAR ENDED MARCH31, 2022, TOGETHER WITH THE REPORT OF THEnnAUDITORS THEREON.n
    1 for0 against
  • TO DECLARE DIVIDEND ON THE EQUITY SHARES FORTHE FINANCIAL YEAR ENDED MARCH 31, 2022.
    1 for0 against
  • TO APPOINT A DIRECTOR IN PLACE OF MR. SANJAYBANSAL (DIN: 00121667), WHO RETIRES BYnnROTATION AND BEING ELIGIBLE, OFFERS HIMSELFFOR RE-APPOINTMENT.n
    1 for0 against
  • TO APPOINT A DIRECTOR IN PLACE OF DR. VIMALKUMAR SHRAWAT (DIN: 08274190), WHO RETIRESnnBY ROTATION AND BEING ELIGIBLE, OFFERSHIMSELF FOR RE-APPOINTMENT.n
    1 for0 against
  • Ratification of Remuneration of Cost Auditors
    1 for0 against
1 proposal not matched to one resolution
  • Re-appointment of M/s Rai Qimat & Associates, Chartered Accountants (Firm Registration No 013152C) as the Statutory Auditors of the Company for a second term of five (5) consecutive years, from the conclusion of this Annual General Meeting (‘AGM’) till the conclusion of the Thirty Forth (34th) AGM of the Company to be held in the year 2027, to examine and audit the accounts of the Company, at such remuneration plus applicable taxes and out of-pocket expenses.MoreLess
    1 for0 against

Mutual fund votes, meeting of 26 Aug 2022, 1 fund house

  • Issuance of up-to 4, 34,500 Equity Shares on preferential basis.
    1 for0 against
  • Issuance of up-to 63,500 Fully Convertible Warrants on preferential basis.
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Fines, tax disputes and stakes in unlisted companies

Reported in the filing for the quarter to Jun 2026.

  • Unlisted stake heldOpal Pharmaceuticals Pty LtdSince 16 Sep 2019

    0.00% bought in the quarter; holding 100.00%, from 100.00%

  • Unlisted stake heldMedicamen Life Sciences Private LimitedSince 12 Aug 2022

    0.00% bought in the quarter; holding 60.00%, from 60.00%

  • Fine or penaltyBombay Stock Exchange (BSE)Since 27 May 2026₹0.01 Cr

    Fines as per SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023 and last updated on January 30,2026 (Chapter VII (A)-Penal Action for Non-Compliance)

    Regulation 19(1)/ 19(2) Non-compliance with the constitution of nomination and remuneration committee
  • Fine or penaltyNational Stock Exchange of India Limited (NSE)Since 27 May 2026₹0.01 Cr

    Fines as per SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023 and last updated on January 30,2026 (Chapter VII (A)-Penal Action for Non-Compliance)

    Regulation 19(1)/ 19(2) Non-compliance with the constitution of nomination and remuneration committee
  • Tax disputeGST Tribunal Jaipur (for show cause notices receved for FY 2017-18)Since 3 Dec 2021
    Pending for Appeal in GST Tribunal
  • Tax disputeGST Tribunal Jaipur (for show cause notices receved for FY 2018-19)Since 3 Dec 2021
    Pending for Appeal in GST Tribunal

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
No
The chair is related to the managing director
No
The filing has a part on fines and penalties
Yes
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.

RaisedAmount raisedForSet asideSpentSpent elsewhere
Preferential IssuesApr 202553.57a) Drug Development of 50 SKUs for Regulated markets b) Registration of dossiers, etc. c) Meet the Enhanced working capital requirements d) Capital expenditure in some area of upgradation of the existing facilities e) Expansion of operations in Domestic Market f) General Corporate Purposes53.5731.57No
₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.